5 Dow Jones Stocks Fell Over 10% in 2025. Here's Why They Are All Contrarian Buys for 2026.

Five Dow components — Home Depot, Procter & Gamble, Nike, Salesforce and UnitedHealth — are more than 10% down in 2025 as weak consumer spending, a sluggish housing market, tariffs and rising medical costs weigh on earnings. Home Depot trades at about 24.1x forward EPS with a 2.7% yield amid discretionary spending weakness; P&G yields 2.9% after preserving margins despite tariff-driven supply-chain pressure; Nike faces margin pressure from tariffs and slower China demand but yields 2.7%. Salesforce, trading at ~22.6x forward with a 0.6% yield, faces product-risk as AI could reduce subscription needs but is deploying agentic AI; UnitedHealth, down roughly a third, faces higher medical costs and a DOJ probe but trades near 20.3x forward with a 2.7% yield, underpinning a value-investor case for selective long positions.

Analysis

Market structure: Weak consumer spending and tariffs are clear winners for defensive staples (PG) and losers for cyclical retail (HD, NKE). SaaS faces a bifurcation — vendors that embed AI (CRM) can consolidate pricing power while pure-seat models risk contraction; CRM trading at ~22.6x forward implies market already discounts some disruption. Cross-asset: weaker retail reduces near-term commodity demand (lumber, nonferrous metals), should modestly lower cyclical inflation pressures and steepen real yields; expect equity vols up in consumer and healthcare names and modest USD strength on risk-off.

Risk assessment: Tail risks include DOJ/indictment outcomes for UNH (material fine or mandated remediation >$2–5bn), tariff escalation hitting NKE/HD margins, or AI adoption cutting SaaS seat counts >10% within 12–24 months. Near-term (days–weeks): earnings/guidance and DOJ filings; medium (3–9 months): CPI/fed moves and housing data; long-term (1–3 years): structural AI re-pricing of software. Hidden dependencies: Medicare Advantage utilization trends for UNH and P&G’s FX hedges; inventory-to-sales ratios at HD can amplify cyclicality.

Trade implications: Establish concentrated, size-limited value longs in PG (2–3% portfolio) and CRM (2% buy-and-hold 12–24 months) while trimming cyclical exposure in NKE (reduce to <1% or short). Use 3–6 month options for convexity: buy 15–20% OTM puts on UNH as tail insurance and sell covered calls on established PG positions to enhance yield. Consider a pair: long PG vs short NKE to express defensive consumer bias with asymmetric downside protection.

Contrarian angles: Consensus underestimates CRM’s ability to expand ARPU via agentic AI — if CRM converts 10–15% of existing seats to paid agents, revenue upside is material and current multiple is cheap. UNH’s ~33% drawdown likely overprices operational recovery but legal tail risk is real; opportunities exist if DOJ disclosures in 30–90 days are clean. Nike’s margin erosion may be cyclical — a decisive recovery in China or successful product innovation could re-rate shares quickly, so size shorts conservatively and use tight stops.

Key Decisions for Investors

• Establish a 2–3% long position in Procter & Gamble (PG) within 2 weeks; target 12–24 month hold, collect ~2.9% yield, add on pullbacks >8% as margin of safety.
• Build a 2% long position in Salesforce (CRM) as a 12–24 month value play; complement with a 1:1 long-call spread (6–12 month expiry) to lever optionality if AI agent uptake accelerates.
• Reduce Nike (NKE) exposure to <1% or initiate a 1–1.5% short position sized to risk appetite; place a hard stop at +15% adverse move and reassess on first-quarter sales/gross-margin print.
• Purchase 3–6 month UNH puts approx. 15–20% OTM sized to 1% of portfolio as tail insurance; if DOJ disclosures within 30–60 days show incremental reserve needs >$2bn, reduce UNH exposure by 50%.
• Execute a pair trade: long PG (2%) vs short NKE (1.5%) to capture defensive rotation; rebalance if CPI falls >0.5% from current level or if housing starts rebound >10% quarter-over-quarter.